0R7 Stock Overview
Produces and sells perfumes, aromas, and natural products. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 2/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
No risks detected for 0R7 from our risk checks.
Robertet SA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €873.00 |
| 52 Week High | €961.00 |
| 52 Week Low | €740.00 |
| Beta | 0.33 |
| 11 Month Change | -7.81% |
| 3 Month Change | 4.93% |
| 1 Year Change | 13.97% |
| 33 Year Change | -9.25% |
| 5 Year Change | -7.81% |
| Change since IPO | 36.19% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0R7 | DE Chemicals | DE Market | |
|---|---|---|---|
| 7D | -8.7% | -3.2% | -1.5% |
| 1Y | 14.0% | -1.1% | 7.9% |
Return vs Industry: 0R7 exceeded the German Chemicals industry which returned -1% over the past year.
Return vs Market: 0R7 exceeded the German Market which returned 8.3% over the past year.
Price Volatility
| 0R7 volatility | |
|---|---|
| 0R7 Average Weekly Movement | 3.3% |
| Chemicals Industry Average Movement | 4.3% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 0R7 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: 0R7's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1850 | 2,153 | Jerome Bruhat | www.robertet.com |
Robertet SA produces and sells perfumes, aromas, and natural products. The company operates in four segments: Raw materials, Fragrances, Flavors, and Active Ingredients. It also produces organic essential oils and active ingredients.
Robertet SA Fundamentals Summary
| 0R7 fundamental statistics | |
|---|---|
| Market cap | €1.81b |
| Earnings (TTM) | €86.35m |
| Revenue (TTM) | €759.29m |
21.0x
P/E Ratio2.4x
P/S RatioIs 0R7 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0R7 income statement (TTM) | |
|---|---|
| Revenue | €759.29m |
| Cost of Revenue | €336.45m |
| Gross Profit | €422.84m |
| Other Expenses | €336.49m |
| Earnings | €86.35m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 41.34 |
| Gross Margin | 55.69% |
| Net Profit Margin | 11.37% |
| Debt/Equity Ratio | 61.8% |
How did 0R7 perform over the long term?
See historical performance and comparison